TMED2 as a marker of prognosis in breast cancer [Letter]

Megan Catherine Schwarz,1 Silvia Allikmets21Icahn School of Medicine, Mount Sinai Oncological Sciences, New York, NY, USA; 2Faculty of Life Sciences & Medicine, GKT School of Medical Education, King’s College London, London, UKWe thank Lin et al for their interesting study proposin...

Full description

Bibliographic Details
Main Authors: Schwarz MC, Allikmets S
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Cancer Management and Research
Subjects:
SC
NSC
Online Access:https://www.dovepress.com/tmed2-as-a-marker-of-prognosis-in-breast-cancer-letter-peer-reviewed-article-CMAR